Urinary infection;Infección urinaria

Actas Urologicas Espanolas

Volumn 26, Issue 8, 2002, Pages 563-573

  Jimenez Cruz J F ^a   Broseta, E ^a   Gobernado, M ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bacteria; Urinary infection; Vaccine

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL VACCINE; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEFALOTIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; NATURAL PRODUCT; NITROFURANTOIN; NONOXINOL 9; PENICILLIN DERIVATIVE; PEPTIDE; PIPEMIDIC ACID; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPERMICIDAL AGENT; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ASYMPTOMATIC BACTERIURIA; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIURIA; BLOOD TOXICITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION SENSITIVITY; KLEBSIELLA; MICROBIOLOGY; PATHOGENESIS; PROTEUS MIRABILIS; REVIEW; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; VACCINATION;

EID: 0036748115     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(02)72829-5     Document Type: Review

References (48)

1. MEDICAL RESEARCH COUNCIL COMITTEE.: Recomended terminology of urinary tract infection. Brit Med J 1979; 2: 717-719.
2. Fuster A, Jiménez Cruz JF.: Terminología y etiopatogenia de las infecciones urinarias. En Broseta E, Jiménez Cruz JF. Infección Urinaria. Madrid. Ed. Aula Médica 1999: 1-10.
3. Stamm WE.: Criteria for the diagnosis of urinary tract infection and for the assesment of therapeutic effectiveness. Infection 1992; 20: 151.
4. Gorelick MH, Shaw KN.: Screening tests for urinary tract infection in children: a meta-analysis. Pediatrics 1999; 104: 54.
5. Bacheller CD, Bernstein JM.: Urinary tract infections. Med Clin North Am 1997; 81: 719-730.
6. Connie R, Mahon G, Manuselis WB.: Textbook of diagnostic microbiology. Philadelphia. Ed. Saunders Co. 1995.
7. Gupta K, Hooton TM, Wobbe CL, Stamm WE.: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 1999; 1: 305-308.
8. Goldstein FW.: Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis 2000; 19: 112-117.
9. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB.: Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 1999; 44: 359-365
10. Queipo JA, Budía A, Jiménez Martí MJ, Mascarós E, Gómez Ferrer A, Gobernado M, Jiménez Cruz JF.: Evolución de las resistencias microbianas a fluorquinolonas en un hospital terciario. Actas Urol Esp 2000, 24: 381-387.
11. Mathai D, Jones RN, Pfaller MA.: The SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 2001 jul; 40: 129-136.
12. Gupta K, Sahm DF, Mayfield D, Stamm WE.: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33: 89-94.
13. Ishihara S, Yokoi S, Ito M, Kobayashi S, Deguchi T.: Pathologic significance of Staphylococcus saprophyticus in complicated urinary tract infections. Urology 2001; 5: 17-20.
14. Worthington T, White J, Lambert P, Adlakha S, Elliot T.: Beta-lactam-dependent coagulase-negative staphylococcus associated with urinary tract infection. Lancet 1999; 354: 1.097.
15. Huebner J, Goldmann DA.: Coagulase-negative staphylococci: role as pathogens. Annu Rev Med 1999; 50: 223-236.
16. Reid G SJ.: Bacterial adhrence in the pathogenesis of urinary tract infection: a review. Rev Infect Dis 1987; 9: 470-487.
17. Schaeffer AJ.: Epitopes of the P-fimbrial adhesin of Escherichia coli and urinary tract infection. J Urol 1997; 158: 1.330.
18. Roberts J, Kaack, MB, Baskin G, Marklund B, Normark S.: Epitopes of the P-fimbrial adhesins of E. coli cause different urinary tract infections. J Urol 1997; 158: 1.610-1.613.
19. Roberts J.: Tropism in bacterial infections in urinary tract infections. J Urol 1996; 156: 1.552-1.559.
20. Warren JW MH, Hebel JR, Trifillis AL.: Cytolethality of hemolytic Escherichia coli to primary human renal proximal tubular cell cultures obtained from different clones. Urology 1995; 45: 706-710.
21. Parson CL SC, Mulholland SG, Griffith DP.: Effect of ammonium on bacterial adherence to bladder transitional epithelium. J Urol 1984; 132: 365-366.
22. Mostafari M SP, Parsons CL.: production of soluble virulence factor by Escherichia coli. J Urol 1995; 153: 1.441-1.443.
23. Parsons C.: Pathogenesis of urinary tract infections. Bacterial adherence, bladder defense mechanism. Urol Clin North Am 1986; 13: 563-568.
24. Dalet F, Del Río G.: Patogenia de las infecciones urinarias. En. Dalet F, del Río G: Infecciones urinarias. Ed. publicaciones E. Barcelona: 1997: 67-124.
25. Stamm WE.: Catheter associated urinary tract infections: epidemiology, pathogenesis and prevention. Am Med 1991; 91: 65-71.
26. Kunin CM, Maccormack K.: Prevention of catheter-induced urinary tract infections by sterile closed drainage. N Eng J Med 1996; 274: 1.155-1.161.
27. Budía A, Jiménez Cruz JF.: Infección urinaria en el paciente sondado. En Broseta E y Jiménez Cruz JF editores: Infección Urinaria. Madrid: Aula Médica 1999: 219-227.
28. Roberts J, Domingue JK, Lewis RW, Kaach B, BASKIN G.: Inmunology of pyelonephritis in the primate model. Effect of superoxide dismutase. J Urol 1982; 128: 1.394-1.400.
29. Sahm D.: Antimicrobial resistence surveillance: The status of E. coli urinary tract isolates. Proceedings of International Symposium on Trends and perspectives in the management of urinary tract infections. Orlando. Florida. March 2000.
30. Felmingham D.: European perspective of antimicrobial resistence amongst UTI pathogens. Proceedings of International Symposium on Trends and perspectives in the management of urinary tract infections. Orlando. Florida. March 2000.
31. Stamm WE.: An epidemic of urinary tract infection? N Eng J Med 2001; 345: 1.055-1.057.
32. Talan D, Stamm WE, Reuning-Scherer J, Churh D.: Ciprofloxacin 7-days vs. TMP/SMX 14-day ± ceftriaxone for acute uncomplicated pyelonephritis: A randomized, double-blind trial. Boston. International Congress of Infectious Diseases. 1998
33. Jiménez Cruz JF, Vidal J, Broseta E.: Ofloxacino en la infección urinaria. Drugs of Today 1992; 28: 27-33.
34. Warren JW.: Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997; 11: 609-622.
35. McGroarty JA, Reid G, Bruce AW.: The influence of nonoxynol-9-containing spermicides on urogenital infection. J Urol 1994, 152: 831-833.
36. Reid G.: Potential preventive strategies and therapies in urinary tract infection. World J Urol 1999; 17: 359-363.
37. Osset J, Bartolome RM, García E, Andreu A.: Assesment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001; 183: 485-491.
38. Shaeffer AJ, Rajan N, Cao Q, Anderson BE, Pruden DL, Sensibar J, Duncan JL.: Host pathogenesis in urinary tract infections. Int J Antimicrob Agents 2001; 17: 245-251.
39. Harrington RD, Hooton TM.: Urinary tract infection risk factors and gender. J Gend Specif Med 2000; 3: 27-34.
40. Hooton TM.: Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001; 17: 259-268.
41. Raz R.: Postmenopausal women with recurent UTI. Int J Antimicrob Agents 2001; 17: 269-271.
42. Kruze D, Biro K, Holzbecher K, Andrial M, Bossart W.: Protection by a polyvalent vaccine against challenge infection and pyelonephritis. Urol Res 1992; 20: 177-181.
43. Nayir A, Emre S, Sirin A, Bulut A, Alpay H, Tanman F.: The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children. Vaccine 1995; 13: 987-990.
44. Uehling DT, Hopkins WJ, Beierle LM, Kryeger JV, Heisey DM.: Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis 2001; 183: 81-83.
45. Pugach JL, Ditizio V, Mittelman MW, Bruce AW, Dicosmo F, Khoury AE.: Antibiotic hydrogel coated Foley catheters for prevention of urinary tract infection in a rabbit model. J Urol 1999; 162: 883-887.
46. Guay DR.: An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001; 61: 353-364.
47. Raz R, Schiller D, Nicolle LE.: Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol 2000; 164: 1.254-1.258.
48. Kunin CM.: Nosocomial urinary tract infections and the indwelling catheter. What is new and what is true? Chest 2001; 120: 10-12.